Harvard Management Company’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-882,129
| Closed | -$6.59M | – | 30 |
|
|
2023
Q2 | $6.59M | Sell |
882,129
-627,125
| -42% | -$4.68M | 0.65% | 12 |
|
|
2023
Q1 | $10.1M | Hold |
1,509,254
| – | – | 1.06% | 16 |
|
|
2022
Q4 | $11.6M | Hold |
1,509,254
| – | – | 1.44% | 8 |
|
|
2022
Q3 | $16.1M | Hold |
1,509,254
| – | – | 2% | 8 |
|
|
2022
Q2 | $12.3M | Hold |
1,509,254
| – | – | 1.42% | 9 |
|
|
2022
Q1 | $10.8M | Hold |
1,509,254
| – | – | 1.09% | 11 |
|
|
2021
Q4 | $25.9M | Hold |
1,509,254
| – | – | 2.43% | 8 |
|
|
2021
Q3 | $34.7M | Hold |
1,509,254
| – | – | 2.04% | 9 |
|
|
2021
Q2 | $55.1M | Buy |
+1,509,254
| New | +$55.1M | 3.17% | 8 |
|